Literature DB >> 3577583

Repeatability of C-peptide response in glucagon stimulation test.

H Sarlund, O Siitonen, M Laakso, K Pyörälä.   

Abstract

Measurement of the plasma C-peptide level before and after iv administration of 1 mg of glucagon was repeated four times in 10 elderly non-diabetic subjects and in 20 elderly non-insulin-dependent diabetics treated with diet or oral drugs to assess the repeatability of the C-peptide responses. Plasma C-peptide levels before and after glucagon administration and C-peptide glucose ratios in the four measurements did not differ significantly from test to test either in diabetic or non-diabetic subjects. The results of the present study indicate that the repeatability of C-peptide response to glucagon is very good both in non-insulin-dependent diabetics and in non-diabetic subjects.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3577583     DOI: 10.1530/acta.0.1140515

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  4 in total

1.  Arginine is preferred to glucagon for stimulation testing of β-cell function.

Authors:  R Paul Robertson; Ralph H Raymond; Douglas S Lee; Roberto A Calle; Atalanta Ghosh; Peter J Savage; Sudha S Shankar; Maria T Vassileva; Gordon C Weir; David A Fryburg
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-08-26       Impact factor: 4.310

Review 2.  Insulin treatment in elderly patients with non-insulin-dependent diabetes mellitus. A double-edged sword?

Authors:  L Niskanen
Journal:  Drugs Aging       Date:  1996-03       Impact factor: 3.923

3.  Long-term metabolic control in recipients of combined pancreas and kidney transplants.

Authors:  H Holdaas; I B Brekke; A Hartmann; O H Bentdal; T Ganes; A Gjellestad; P Fauchald; K J Berg; O Djøseland; J Jervell
Journal:  Diabetologia       Date:  1991-08       Impact factor: 10.122

Review 4.  There is Kisspeptin - And Then There is Kisspeptin.

Authors:  Mehboob A Hussain; Woo-Jin Song; Andrew Wolfe
Journal:  Trends Endocrinol Metab       Date:  2015-10       Impact factor: 12.015

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.